AbbVie
ABBV
ABBV
2,992 hedge funds and large institutions have $186B invested in AbbVie in 2022 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 1,150 increasing their positions, 1,319 reducing their positions, and 138 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,992
Holders Change
-49
Holders Change %
-1.61%
% of All Funds
50.59%
Holding in Top 10
329
Holding in Top 10 Change
+33
Holding in Top 10 Change %
+11.15%
% of All Funds
5.56%
New
129
Increased
1,150
Reduced
1,319
Closed
138
Calls
$3.01B
Puts
$2.54B
Net Calls
+$477M
Net Calls Change
+$234M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
$6.61B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
$4.03B |
| 3 |
Morgan Stanley
New York
|
$3.99B |
| 4 |
BlackRock
New York
|
$20.6B |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$23.5B |
